These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 406560)

  • 1. Acute leukemia after alkylating-agent therapy of ovarian cancer.
    Reimer RR; Hoover R; Fraumeni JF; Young RC
    N Engl J Med; 1977 Jul; 297(4):177-81. PubMed ID: 406560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials.
    Greene MH; Boice JD; Greer BE; Blessing JA; Dembo AJ
    N Engl J Med; 1982 Dec; 307(23):1416-21. PubMed ID: 6752720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute leukemia in advanced ovarian carcinoma after treatment with alkylating agents.
    Sotrel G; Jafari K; Lash AF; Stepto RC
    Obstet Gynecol; 1976 Jan; 47(1):67S-71S. PubMed ID: 1061006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemia following chemotherapy for ovarian cancer.
    Kaldor JM; Day NE; Pettersson F; Clarke EA; Pedersen D; Mehnert W; Bell J; Høst H; Prior P; Karjalainen S
    N Engl J Med; 1990 Jan; 322(1):1-6. PubMed ID: 2104664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of leukemia after chemotherapy and radiation treatment for breast cancer.
    Curtis RE; Boice JD; Stovall M; Bernstein L; Greenberg RS; Flannery JT; Schwartz AG; Weyer P; Moloney WC; Hoover RN
    N Engl J Med; 1992 Jun; 326(26):1745-51. PubMed ID: 1594016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute leukaemia after alkylating-agent therapy of ovarian cancer.
    Bell DR; Woods RL; Levi JA
    Med J Aust; 1982 Sep; 2(5):243-4. PubMed ID: 7132879
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute myeloid leukemia and other myelopathic disorders following treatment with alkylating agents.
    Bennett JM; Moloney WC; Greene MH; Boice JD
    Hematol Pathol; 1987; 1(2):99-104. PubMed ID: 3504435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.
    Pedersen-Bjergaard J; Ersbøll J; Sørensen HM; Keiding N; Larsen SO; Philip P; Larsen MS; Schultz H; Nissen NI
    Ann Intern Med; 1985 Aug; 103(2):195-200. PubMed ID: 4014901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemia after treatment of ovarian cancer with alkylating agents.
    Parker LM
    N Engl J Med; 1983 Jun; 308(23):1422. PubMed ID: 6843637
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of leukemia after platinum-based chemotherapy for ovarian cancer.
    Travis LB; Holowaty EJ; Bergfeldt K; Lynch CF; Kohler BA; Wiklund T; Curtis RE; Hall P; Andersson M; Pukkala E; Sturgeon J; Stovall M
    N Engl J Med; 1999 Feb; 340(5):351-7. PubMed ID: 9929525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of secondary acute nonlymphocytic leukemias. Cytological aspects (a review).
    Raposa T; Várkonyi J; Gráf F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(2):180-5. PubMed ID: 6208100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemia following chemotherapy for breast cancer.
    Curtis RE; Boice JD; Moloney WC; Ries LG; Flannery JT
    Cancer Res; 1990 May; 50(9):2741-6. PubMed ID: 2328500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of leukemia associated with the first course of cancer treatment: an analysis of the Surveillance, Epidemiology, and End Results Program experience.
    Curtis RE; Hankey BF; Myers MH; Young JL
    J Natl Cancer Inst; 1984 Mar; 72(3):531-44. PubMed ID: 6583439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Induced malignant hemopathies. 6 new cases with 1 patient surviving 45 months].
    Clément F
    Schweiz Med Wochenschr; 1979 Apr; 109(15):544-51. PubMed ID: 286415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of acute erythroleukemia in B-cell immunoproliferative disorders after prolonged therapy with alkylating drugs.
    Cardamone JM; Kimmerle RI; Marshall EY
    Am J Med; 1974 Nov; 57(5):836-42. PubMed ID: 4216270
    [No Abstract]   [Full Text] [Related]  

  • 18. [Plasmocytoma, alkylating agents, and acute myeloid leukemia (author's transl)].
    Schmalzl F; Keiser G; Kresbach E; Fritz H; Asamer H; Braunsteiner H
    Dtsch Med Wochenschr; 1975 Sep; 100(39):1961-7. PubMed ID: 1057506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myeloid leukaemia after treatment with cytostatic agents.
    Smit CG; Meyler L
    Lancet; 1970 Sep; 2(7674):671-2. PubMed ID: 4195813
    [No Abstract]   [Full Text] [Related]  

  • 20. [A patient with ovarian cancer metastasis cured (?) by cytostatic agents and died from acute myeloid leukemia].
    Sypkens Smit CG; Meyler L
    Ned Tijdschr Geneeskd; 1970 Sep; 114(39):1620-3. PubMed ID: 4990178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.